Multidisciplinary management of TNBC Integrating immunotherapies for early and metastatic disease
Update: 2025-06-25
Description
touchEXPERT FOCUS for touchONCOLOGY
Listen to a series of short interviews with three leading experts discussing the application of immunotherapy in triple-negative breast cancer (TNBC). The experts explore the latest data and guideline recommendations for immunotherapy in early-stage and metastatic TNBC, and how to maximize treatment benefits.
The experts:
- Prof. Sherko Kümmel – Kliniken Essen-Mitte, Essen, Germany
- Prof. Rebecca Dent – National Cancer Center Singapore, Singapore
- Prof. Peter Schmid – Barts Cancer Institute, London, UK
This touchPODCAST is for healthcare professionals outside of the UK.
This activity is funded by an independent medical education grant from Merck Sharp & Dohme LLC.
This activity is jointly provided by USF Health and touchIME.
touchIME is an EBAC® accredited provider.
For further information visit our website:
https://touchoncologyime.org/management-of-tnbc-with-immunotherapy/
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
